AmCad BioMed

AmCad BioMed is a Taiwan-based medical device company specializing in the development of Computer-Aided Detection and Diagnosis (CAD) software. The company leverages advanced image processing and artificial intelligence to assist clinicians in the early detection and diagnosis of various conditions, including thyroid cancer and obstructive sleep apnea. Their flagship products include AmCad-UT for thyroid nodule analysis and AmCad-UO for rapid sleep apnea screening. AmCad BioMed is publicly traded on the Taipei Exchange and holds multiple FDA and CE Mark clearances for its diagnostic solutions. The company continues to expand its portfolio into liver fibrosis and breast cancer detection using its proprietary ultrasound imaging technologies.